Lv1
40 积分 2024-11-10 加入
CSNK2A2 promotes hepatocellular carcinoma progression through activation of NF-κB pathway
3天前
已完结
Respiratory viral infections awaken metastatic breast cancer cells in lungs
16天前
已完结
Site-specific mutagenesis screening in KRAS mutant library to uncover resistance mechanisms to KRASG12D inhibitors
1个月前
已完结
Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor
1个月前
已完结
Critically Reviewing Literature: A Tutorial for New Researchers
1个月前
已完结
Concurrent loss of the Y chromosome in cancer and T cells impacts outcome
2个月前
已完结
Vascular Normalization Augments the Anti-tumor Efficacy of Combined HDAC Inhibitor with Immunotherapy in Solid Tumors
2个月前
已完结
KRAS inhibitors: resistance drivers and combinatorial strategies
3个月前
已完结
Mutant KRAS and CK2 Cooperatively Stimulate SLC16A3 Activity to Drive Intrahepatic Cholangiocarcinoma Progression
3个月前
已完结
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer
4个月前
已完结
皖公网安备34019202002308
